Advertisement

The Isolation and Enrichment of Large Numbers of Highly Purified Mouse Spleen Dendritic Cell Populations and Their In Vitro Equivalents

  • David VremecEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1423)

Abstract

Dendritic cells (DCs) form a complex network of cells that initiate and orchestrate immune responses against a vast array of pathogenic challenges. Developmentally and functionally distinct DC subtypes differentially regulate T-cell function. Importantly it is the ability of DC to capture and process antigen, whether from pathogens, vaccines, or self-components, and present it to naive T cells that is the key to their ability to initiate an immune response. Our typical isolation procedure for DC from murine spleen was designed to efficiently extract all DC subtypes, without bias and without alteration to their in vivo phenotype, and involves a short collagenase digestion of the tissue, followed by selection for cells of light density and finally negative selection for DC. The isolation procedure can accommodate DC numbers that have been artificially increased via administration of fms-like tyrosine kinase 3 ligand (Flt3L), either directly through a series of subcutaneous injections or by seeding with an Flt3L secreting murine melanoma. Flt3L may also be added to bone marrow cultures to produce large numbers of in vitro equivalents of the spleen DC subsets. Total DC, or their subsets, may be further purified using immunofluorescent labeling and flow cytometric cell sorting. Cell sorting may be completely bypassed by separating DC subsets using a combination of fluorescent antibody labeling and anti-fluorochrome magnetic beads. Our procedure enables efficient separation of the distinct DC subsets, even in cases where mouse numbers or flow cytometric cell sorting time is limiting.

Key words

Dendritic cell DC purification DC expansion DC subtypes Conventional DCs Plasmacytoid DCs 

Notes

Acknowledgements

This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIIS.

References

  1. 1.
    Steinman RM, Kohn ZA (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137:1142–1162CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271–296CrossRefPubMedGoogle Scholar
  3. 3.
    Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, Wu S, Vuthoori S, Ko K, Zavala F, Pamer EG, Littman DR, Lang RA (2002) In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17:211–220CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Liu CH, Fan YT, Dias A, Esper L, Corn RA, Bafica A, Machado FS, Aliberti J (2006) Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. J Immunol 177:31–35CrossRefPubMedGoogle Scholar
  5. 5.
    Ciavarra RP, Stephens A, Nagy S, Sekellick M, Steel C (2006) Evolution of immunological paradigms in a virus model: are dendritic cells critical for antiviral immunity and viral clearance? J Immunol 177:492–500CrossRefPubMedGoogle Scholar
  6. 6.
    Watanabe N, Wang YH, Lee HK, Ito T, Cao W, Liu YJ (2005) Hassall’s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 436:1181–1185CrossRefPubMedGoogle Scholar
  7. 7.
    Luo X, Tarbell KV, Yang H, Pothoven K, Bailey SL, Dind R, Steinman RM, Suthanthiran M (2007) Dendritic cells with TGF-β1 differentiate naïve CD4+CD25 T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 104:2821–2826CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Yamazaki S, Iyoda T, Tarbell K, Olson K, Velinzon K, Inaba K, Steinman RM (2003) Direct expansion of functional CD25+CD4+ regulatory T cells by antigen presenting dendritic cells. J Exp Med 198:235–247CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Crowley M, Inaba K, Witmer-Pack M, Steinman RM (1989) The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus. Cell Immunol 118:108–125CrossRefPubMedGoogle Scholar
  10. 10.
    Vremec D, Zorbas M, Scollay R, Saunders D, Ardavin C, Wu L, Shortman K (1992) The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med 176:47–58CrossRefPubMedGoogle Scholar
  11. 11.
    Shortman K, Heath WR (2010) The CD8+ dendritic cell subset. Immunol Rev 234:18–31CrossRefPubMedGoogle Scholar
  12. 12.
    Shortman K, Caux C (1997) Dendritic cell development: multiple pathways to natures adjuvant. Stem Cells 15:409–419CrossRefPubMedGoogle Scholar
  13. 13.
    Shortman K, Liu YJ (2002) Mouse and human dendritic cell subtypes. Nat Rev Immunol 2:151–161CrossRefPubMedGoogle Scholar
  14. 14.
    Vremec D, Shortman K (1997) Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes on incubation and differences between thymus, spleen and lymph nodes. J Immunol 159:565–573PubMedGoogle Scholar
  15. 15.
    Wilson NS, El-Sukkari D, Belz GT, Smith CM, Steptoe RJ, Heath WR, Shortman K, Villadangos JA (2003) Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102:2187–2194CrossRefPubMedGoogle Scholar
  16. 16.
    Villadangos JA, Schnorrer P (2007) Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 7:543–555CrossRefPubMedGoogle Scholar
  17. 17.
    Heath WR, Kurts C, Miller JF, Carbone FR (1998) Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med 187:1549–1553CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Heath WR (2004) Cross presentation, dendritic cell subsets, and generation of immunity to cellular antigens. Immunol Rev 199:9–26CrossRefPubMedGoogle Scholar
  19. 19.
    Vremec D, O’Keeffe M, Wilson A, Ferrero I, Koch U, Radtke F, Scott B, Hertzog P, Villadangos J, Shortman K (2011) Factors determining the spontaneous activation of splenic dendritic cells in culture. Innate Immun 17:338–352CrossRefPubMedGoogle Scholar
  20. 20.
    Vremec D, Pooley J, Hochrein H, Wu L, Shortman K (2000) CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 164:2978–2986CrossRefPubMedGoogle Scholar
  21. 21.
    Vremec D (2010) The isolation of mouse dendritic cells from lymphoid tissues and the identification of dendritic cell subtypes by multiparameter flow cytometry. In: Naik SH (ed) Dendritic cell protocols, vol 595, Methods in molecular biology. Humana, New York, pp 205–229CrossRefGoogle Scholar
  22. 22.
    O’Keeffe M, Hochrein H, Vremec D, Caminschi I, Miller JL, Anders EM, Wu L, Lahoud MH, Henri S, Scott B, Hertzog P, Tatarczuch L, Shortman K (2002) Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8+ dendritic cells only after microbial stimulus. J Exp Med 196:1307–1319CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Naik SH, Shortman K (2007) Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7:19–30CrossRefPubMedGoogle Scholar
  24. 24.
    Asselin-Paturel C, Brizard G, Pin J-J, Briere F, Trinchieri G (2003) Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 171:6466–6477CrossRefPubMedGoogle Scholar
  25. 25.
    Naik SH, Proietto AI, Wilson NS, Dakic A, Schnorrer P, Fuchsberger M, Lahoud MH, O’Keeffe M, Shao QX, Chen WF, Villadangos JA, Shortman K, Wu L (2005) Cutting edge: generation of splenic CD8+ and CD8 dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol 174:6592–6597CrossRefPubMedGoogle Scholar
  26. 26.
    Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, Kaisho T, Akira S, Reis e Sousa C (2003) Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8α+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 33:827–833CrossRefPubMedGoogle Scholar
  27. 27.
    Hochrein H, Shortman K, Vremec D, Scott B, Hertzog P, O’Keeffe M (2001) Differential production of IL-12, IFN-α and IFN-γ by mouse dendritic cell subsets. J Immunol 166:5448–5455CrossRefPubMedGoogle Scholar
  28. 28.
    Lauterbach H, Bathke B, Gilles S, Traidl-Hoffman C, Luber CA, Fejer G, Freudenberg MA, Davey GM, Vremec D, Kallies A, Wu L, Shortman K, Chaplin P, Suter M, O’Keeffe M, Hochrein H (2010) Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to polyIC. J Exp Med 207:2703–2717CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Den Haan JM, Lehar SM, Bevan MJ (2000) CD8+ but not CD8 dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192:1685–1696CrossRefGoogle Scholar
  30. 30.
    Pooley JL, Heath WR, Shortman K (2001) Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8 dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol 166:5327–5330CrossRefPubMedGoogle Scholar
  31. 31.
    Zhang JG, Czabotar PE, Policheni AN, Caminschi I, Wan SS, Kitsoulis S, Tullett KM, Robin AY, Brammananth R, van Delft MF, Lu J, O’Reilly LA, Joseffson EC, Kile BT, Chin WJ, Mintern JD, Olshina MA, Wong W, Baum J, Wright MD, Huang DCS, Mohandas N, Coppel RL, Colman PM, Nicola NA, Shortman K, Lahoud M (2012) The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity 36:646–657CrossRefPubMedGoogle Scholar
  32. 32.
    Zelenay S, Keller AM, Whitney PG, Schraml BU, Deddouche S, Rogers NC, Schulz O, Sancho D, Reis e Sousa C (2012) The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favour cross-priming of CTLs in virus-infected mice. J Clin Invest 122:1615–1627CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Caminschi I, Proietto AI, Ahmet F, Kitsoulis S, Teh JS, Lo JCY, Rizzitelli A, Wu L, Vremec D, van Dommelen SLH, Campbell IK, Maraskovsky E, Braley B, Davey GM, Mottram P, van de Velde N, Jensen K, Lew AM, Wright MD, Heath WR, Shortma K, Lahoud MH (2008) The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 112:3264–3273CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Sathe P, Pooley J, Vremec D, Mintern J, Jin JO, Wu L, Kwak JY, Villadangos JA, Shortman K (2011) The acquisition of antigen cross-presentation function by newly formed dendritic cells. J Immunol 186:5184–5192CrossRefPubMedGoogle Scholar
  35. 35.
    Zhan Y, Carrington EM, van Nieuwenhuijze A, Bedoui S, Seah S, Xu Y, Wang N, Mintern JD, Villadangos JA, Wicks IP, Lew AM (2011) GM-CSF increases cross-presentation and CD103 expression by mouse CD8+ spleen dendritic cells. Eur J Immunol 41:2585–2595CrossRefPubMedGoogle Scholar
  36. 36.
    Lewis KL, Caton ML, Bogunovic M, Greter M, Grajkowska LT, Ng D, Klinakis A, Charo IF, Jung S, Gommerman JL, Ivanov II, Liu K, Merad M, Reizis B (2011) Notch2 receptor signalling controls functional differentiation of dendritic cells in the spleen and intestine. Immunity 35:780–791CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki S, Cheong C, Liu K, Lee HW, Park CG, Steinman RM, Nussenzweig MC (2007) Differential antigen processing by dendritic cell subsets in vivo. Science 315:107–111CrossRefPubMedGoogle Scholar
  38. 38.
    Proietto AI, O’Keeffe M, Gartlan K, Wright MD, Shortman K, Wu L, Lahoud MH (2004) Differential production of inflammatory chemokines by murine dendritic cell subsets. Immunobiology 209:163–172CrossRefPubMedGoogle Scholar
  39. 39.
    Onai N, Obata-Onai A, Schmid MA, Manz MG (2007) Flt3 in regulation of type I interferon-producing cell and dendritic cell development. Ann N Y Acad Sci 1106:253–261CrossRefPubMedGoogle Scholar
  40. 40.
    Schmid MA, Kingston D, Boddupalli S, Manz MG (2010) Instructive cytokine signals in dendritic cell lineage commitment. Immunol Rev 234:32–44CrossRefPubMedGoogle Scholar
  41. 41.
    McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, Maliszewski CR, Lynch DH, Smith J, Pulendran B, Roux ER, Teepe M, Lyman SD, Peschon JJ (2000) Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells and natural killer cells. Blood 95:3489–3497PubMedGoogle Scholar
  42. 42.
    Waskow C, Liu K, Darrasse-Jeze G, Guermonprez P, Ginhoux F, Merad M, Shengelia T, Yao K, Nussenzweig M (2008) The receptor tyrosine kinase Flt3 is required for dendritic ell development in peripheral lymphoid tissues. Nat Immunol 9:676–683CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Kingston D, Schmid MA, Onai N, Obata-Onai A, Baumjohann D, Manz MG (2009) The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 114:835–843CrossRefPubMedGoogle Scholar
  44. 44.
    D’Amico A, Wu L (2003) The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J Exp Med 198:293–303CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K, McKenna HJ (1996) Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 184:1953–1962CrossRefPubMedGoogle Scholar
  46. 46.
    Mach N, Gillessen B, Wilson SB, Sheehan C, Mihm M, Dranoff G (2000) Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res 60:3239–3246PubMedGoogle Scholar
  47. 47.
    Brasel K, De Smedt T, Smith JL, Maliszewski CR (2000) Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96:3029–3039PubMedGoogle Scholar
  48. 48.
    Gilliet M, Boonstra A, Paturel C, Antonenko S, Xu XL, Trinchieri G, O’Garra A, Liu YJ (2002) The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT-3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med 195:953–958CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Bedoui S, Prato S, Mintern J, Gebhardt T, Zhan Y, Lew AM, Heath WR, Villadangos JA, Segura E (2009) Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses. J Immunol 182:4200–4207CrossRefPubMedGoogle Scholar
  50. 50.
    Segura E, Kapp E, Gupta N, Wong J, Lim J, Ji H, Heath WR, Simpson R, Villadangos JA (2010) Differential expression of pathogen-recognition molecules between dendritic cell subsets revealed by plasma membrane proteomic analysis. Mol Immunol 47:1765–1773CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.The Walter and Eliza Hall Institute of Medical ResearchParkvilleAustralia

Personalised recommendations